We are live on ! Find out more
CCA

Catalyst Capital Advisors Portfolio holdings

AUM $6.03B
1-Year Est. Return 24.5%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+24.5%
3 Year Est. Return
+62.66%
5 Year Est. Return
+62.45%
10 Year Est. Return
+241.55%
AUM
$852M
AUM Growth
+$76.1M
Cap. Flow
+$55.5M
Cap. Flow %
6.51%
Top 10 Hldgs %
20.23%
Holding
627
New
206
Increased
135
Reduced
67
Closed
135

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$14.3M
2
TDG icon
TransDigm Group
TDG
+$14M
3
DKS icon
Dick's Sporting Goods
DKS
+$13.8M
4
HLF icon
Herbalife
HLF
+$13.7M
5
NRG icon
NRG Energy
NRG
+$12M

Sector Composition

Rank Sector Weight
1 Healthcare 14.77%
2 Technology 14.32%
3 Industrials 13.05%
4 Consumer Discretionary 12.47%
5 Financials 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPST icon
51
Tempest Therapeutics
TPST
$14.8M
$5.18M 0.61%
40
-1
-2% -$73.2K
LHX icon
52
L3Harris
LHX
$55.9B
$5.16M 0.61%
+71,806
New +$4.97M
TPR icon
53
Tapestry
TPR
$28.8B
$5.11M 0.6%
135,984
-308,016
-69% -$10.9M
CL icon
54
Colgate-Palmolive
CL
$72.6B
$5.05M 0.59%
+73,062
New +$4.93M
NVAX icon
55
Novavax
NVAX
$1.23B
$5.02M 0.59%
42,300
+500
+1% +$52.3K
LLTC
56
DELISTED
Linear Technology Corp
LLTC
$5.01M 0.59%
+109,883
New +$4.78M
FL
57
DELISTED
Foot Locker
FL
$4.88M 0.57%
+86,909
New +$4.82M
ROK icon
58
Rockwell Automation
ROK
$51.4B
$4.88M 0.57%
+43,875
New +$4.81M
GAP
59
The Gap Inc
GAP
$6.84B
$4.88M 0.57%
115,758
+13,868
+14% +$544K
EMR icon
60
Emerson Electric
EMR
$82.9B
$4.81M 0.56%
+77,857
New +$4.88M
NTAP icon
61
NetApp
NTAP
$32.9B
$4.73M 0.55%
114,034
-2,214
-2% -$91.9K
GSAT icon
62
Globalstar
GSAT
$10.2B
$4.54M 0.53%
+110,000
New +$4.22M
MESG
63
DELISTED
XURA INC COM (DE)
MESG
$4.23M 0.5%
225,299
+12,500
+6% +$253K
IBM icon
64
IBM
IBM
$202B
$4.14M 0.49%
26,973
-114
-0.4% -$18.1K
LE icon
65
Lands' End
LE
$361M
$3.97M 0.47%
73,500
+1,000
+1% +$47.1K
LUV icon
66
Southwest Airlines
LUV
$22.1B
$3.39M 0.4%
80,000
BBG
67
DELISTED
Bill Barrett Corp
BBG
$3.3M 0.39%
+290,000
New +$3.83M
INO icon
68
Inovio Pharmaceuticals
INO
$79.8M
$3.26M 0.38%
29,583
MDRX
69
DELISTED
Veradigm Inc. Common Stock
MDRX
$3.19M 0.37%
+250,000
New +$3.18M
ENBL
70
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$3.17M 0.37%
163,500
-160,000
-49% -$3.54M
AKS
71
DELISTED
AK Steel Holding Corp
AKS
$3.12M 0.37%
+525,000
New +$3.3M
JWN
72
DELISTED
Nordstrom
JWN
$3.02M 0.35%
38,000
+27,658
+267% +$2.03M
PAYX icon
73
Paychex
PAYX
$40.4B
$2.96M 0.35%
64,000
-37,675
-37% -$1.74M
SWKS icon
74
Skyworks Solutions
SWKS
$9.06B
$2.92M 0.34%
40,243
+1,070
+3% +$66.4K
SHW icon
75
Sherwin-Williams
SHW
$78.3B
$2.89M 0.34%
+33,000
New +$2.6M

Similar funds

Catalyst Capital Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Catalyst Capital Advisors held 627 positions worth $852M, up 9.8% from $776M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Catalyst Capital Advisors deployed $55.5M of net new capital in Q4 2014, opening 206 new positions and adding to 135 existing holdings. Its largest new stake was Freeport-McMoran: 650,000 shares worth $15.2M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 9.7% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was GE Aerospace, an estimated $14.3M trimmed.

  • Catalyst Capital Advisors's largest Q4 2014 buy was Freeport-McMoran: 650,000 shares worth $15.2M.
  • Catalyst Capital Advisors added most to Bausch Health in Q4 2014, an estimated $16.5M increase.
  • Catalyst Capital Advisors's biggest Q4 2014 reduction was GE Aerospace, cutting an estimated $14.3M.
  • Catalyst Capital Advisors fully exited Herbalife in Q4 2014, selling an estimated $13.7M.
  • Catalyst Capital Advisors's ten largest holdings make up 20% of its $852M portfolio in Q4 2014.
  • Catalyst Capital Advisors opened 206 new positions and closed 135 in Q4 2014.
  • Catalyst Capital Advisors's portfolio value rose 9.8% quarter-over-quarter to $852M.

Based on Catalyst Capital Advisors's 13F filing for Q4 2014, filed 10 Feb 2015.